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Summary
Malaria parasites undergo a population expansion
inside the host liver before disease onset. Develop-
mental arrest inside host hepatocytes elicits pro-
tective immune responses. Therefore, elucidation of
the molecular mechanisms leading to mature hepatic
merozoites, which initiate the pathogenic blood
phase, also informs anti-malaria vaccine strategies.
Using targeted gene deletion in the rodent model
malaria parasite Plasmodium berghei, we show that a
Plasmodium-speciﬁc Apicoplast protein plays an
important role for Liver Merozoite formation (PALM).
While the resulting knockout mutants develop nor-
mally for most of the life cycle, merozoite release into
the blood stream and the ability to establish an infec-
tion are severely impaired. Presence of a signature
blood-stage antigen, merozoite surface protein 1 and
normal apicoplast morphology indicate that the
inability to ﬁnalize merozoite segregation is a direct
consequence of loss of PALM function. Experimental
immunization of mice with as few as two doses of
palm- sporozoites can elicit sterile protection up to
110 days after ﬁnal immunization. Our data establish
that a tailor-made arrest in the ﬁnal steps of hepatic
merozoite formation can induce strong protective
immune responses and that malaria parasites employ
a distinct apicoplast protein for efficient formation of
pre-erythrocytic merozoites.
Introduction
Malaria parasites are obligate intracellular eukaryotic
pathogens that belong to the phylum Apicomplexa. Plas-
modium falciparum is a major cause of childhood mortality
in sub-Saharan Africa and continues to be the most
prevalent and fatal arthropod-borne infectious disease
[World Health Organization (WHO), 2011].
Plasmodium species follow a complex developmental
programme of stage conversions as they progress
through their life cycles (Prudencio et al., 2006; Silvie
et al., 2008a). After transmission through infectious
Anopheles bites, the motile sporozoites rapidly migrate
through the skin and enter a blood capillary (Amino et al.,
2006). Sporozoites pass to the liver where they adhere to
the endothelium of the sinusoid. There, they enter by
breaching Kupffer cells and several hepatocytes before
ﬁnally taking residence in a suitable hepatocyte (Mota
et al., 2001; Frevert et al., 2005). Target cell entry coin-
cides with the formation of a replication-competent niche,
termed the parasitophorous vacuole, which originates
from the host cell plasma membrane (Sibley, 2011). The
parasitophorous vacuole membrane prevents fusion of
the developing parasite with endosomal compartments,
thus providing a safe environment for liver-stage
development. After a few days of extensive growth and
replication, thousands of ﬁrst-generation merozoites are
released into the blood stream in vesicles termed
merosomes (Sturm et al., 2006). After being released in
the pulmonary microvasculature (Baer et al., 2007), free
merozoites quickly invade red blood cells, thus initiating
a malaria blood-stage infection. The subsequent fast
rounds of asexual replication within host erythrocytes
allow the parasite to multiply exponentially and are the
exclusive cause of the clinical manifestations of malaria
(Haldar et al., 2007).
Ahallmark of apicomplexan parasites is the presence of
a vestigial organelle, termed apicoplast, acquired by
secondary endosymbiosis of a red alga (Janouskovec
et al., 2010). The apicoplast contains a 35 kb circular DNA
encoding two rRNA units, 25 tRNA units and 30 mainly
housekeeping proteins (Wilson et al., 1996). Most of its
metabolic activity comes from an estimated 500–600
nuclear-encoded proteins that are imported using a bipar-
tite leader sequence (Waller et al., 2000). Although the
apicoplast has long since lost its photosynthetic function-
ality, a number of important functions have been retained,
most notably the biosynthesis of fatty acids, haem and
isopentenyl diphosphate (Ralph et al., 2004). All three
pathways differ considerably from those found in the host.
Moreover, this unique organelle is indispensable for
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© 2011 Blackwell Publishing Ltdparasite survival, which has made it one of the leading
targets for novel anti-malarial drug development. For
instance, fosmidomycin interferes with the nonmeva-
lonate pathway of isoprenoid biosynthesis (Jomaa et al.,
1999), while several antibiotic agents act as apicoplast
translation inhibitors (Dahl and Rosenthal, 2007), thus
causing a so-called delayed death phenotype (Fichera
and Roos, 1997).
Irradiation-induced arrest of liver-stage maturation
induces strong protective immune responses in the host
(Nussenzweig et al., 1967; Hoffman et al., 2010). Using
experimental genetics, loss-of-function mutants display-
ing a deﬁned developmental arrest before parasite repli-
cation have been generated. Consecutive delivery of
these genetically arrested parasites elicits protection
against reinfection (van Dijk et al., 2005; Mueller et al.,
2005a,b; 2007). Therefore, characterization of Plasmo-
dium genes that are important for liver-stage development
also informs anti-malaria vaccine development.
More recently, mutants that display an arrest in late
liver-stage development have been described. Deﬁcien-
cies in the type II fatty acid biosynthesis (FASII) pathway
lead to premature arrest, as evident from the absence of
signature proteins of mature blood-stage infectious para-
sites (Yu et al., 2008; Vaughan et al., 2009; Pei et al.,
2010). Targeted deletion of liver-speciﬁc protein 1 (LISP1)
leads to formation of hepatic merozoites but a partial
defect in parasitophorous vacuole membrane rupture
(Ishino et al., 2009). Sporozoite-speciﬁc ablation of the
vital cGMP-dependent kinase revealed that mutant para-
sites are unable to complete liver-stage development
(Falae et al., 2010). However, it remains to be shown
whether these parasites are still able to ﬁnalize merozoite
formation and whether they express any blood-stage
proteins.
Here, we demonstrate the importance of a previously
uncharacterized Plasmodium-speciﬁc apicoplast protein
for liver merozoite formation (PALM) and its requirement
for efficient transition to a blood-stage infection.
Results
Identiﬁcation of a candidate Plasmodium liver
stage-speciﬁc protein
To identify Plasmodium genes with a speciﬁc critical func-
tion in liver merozoite formation, we systematically
searched available data sets for potential liver stage-
speciﬁc genes of unknown function. We focused on a
small Plasmodium-speciﬁc gene (PBANKA_010110)
expressed during liver-stage development (Tarun et al.,
2008). The only additional expression data available are
from a recent RNA sequencing effort of synchronous
P. falciparum blood stages that revealed negligible PALM
transcription levels with a slight upregulation in mature
blood stages (Otto et al., 2010). Orthologues were readily
identiﬁed in other Plasmodium species but not in any
other apicomplexan parasite. Using cross-species com-
parisons, we manually re-annotated the Plasmodium
berghei gene and were able to identify a previously unrec-
ognized apicoplast targeting sequence (Fig. 1A). In addi-
tion, we noticed a central, highly conserved domain that
contains two strictly conserved cysteine residues (Fig. 1A
and B).
PALM is upregulated in Plasmodium liver stages and
localizes to the apicoplast
To detect PALM throughout the parasite life cycle, we
attempted to raise speciﬁc peptide antibodies, but the
obtained sera gave non-speciﬁc signals (data not shown).
As an alternative, we generated a parasite line, using a
P. berghei ANKA clone constitutively expressing GFP
(ANKA-GFP; Janse et al., 2006), with the endogenous
PALM protein fused to the red ﬂuorescent protein
mCherry (Shaner et al., 2004) and a quadruple myc tag
(Fig. 2A and B). The resulting transgenic PALM-mCherry-
myc parasites completed the full life cycle without any
Fig. 1. The Plasmodium-speciﬁc apicoplast protein important for
liver merozoite formation (PALM).
A. Primary structure of Plasmodium PALM proteins. Shown are the
overall sequence structures and amino acid sequence identities of
PALM orthologues in P. yoelii (PY01863), P. falciparum (PFF0110w)
and P. vivax (PVX_113280), compared with P. berghei PALM
(PBANKA_010110). Signal peptide (red), apicoplast-targeting
sequence (green) as predicted with PlasmoAP (Foth et al., 2003),
and the conserved domain (grey) with two signature cysteine
residues (yellow) are shown.
B. Sequence alignment of Plasmodium PALM proteins. Shown is
the conserved domain (A) with the two signature cysteine residues
(highlighted yellow). P. berghei PALM, PBANKA_010110; P. yoelii
PALM, PY01863; P. chabaudi PALM, PCHAS_010180; P. falciparum
PALM, PFF0110w; P. vivax PALM, PVX_113280; P. knowlesi PALM,
PKH_114760.
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three C57BL/6 mice bitten by three PALM-mCherry-myc
parasite-infected mosquitoes each became patent on day
4. We ﬁrst monitored PALM expression in live parasites.
We observed structured, albeit weak, signals in in vitro
cultured liver-stage parasites (Fig. 2C). Absence of a
detectable signal in any of the other life cycle stages
indicated that PALM expression levels in general are low,
with the exception of mature liver stages.
We next employed indirect immunoﬂuorescence
microscopy using mouse anti-myc antibodies on ﬁxed
parasites, to take advantage of the quadruple myc epitope
(Fig. 3). In good agreement with the report of low levels of
PALM transcripts in mature blood stages (Otto et al.,
2010), we were able to detect a structured PALM signal in
mature asexual blood stages but not in ring stages or
trophozoites. Moreover, we observed a structured stain-
ing inside developing Plasmodium oocysts that segre-
gated in mature oocysts, as well as a single dot in salivary
gland sporozoites, indicative of the apicoplast. These ﬁnd-
ings are in good agreement with the previously unrecog-
nized apicoplast targeting signal (Fig. 1A).
To further corroborate localization of PALM to this ves-
tigial organelle, we focused on liver stages where the
PALM signal is most prominent. We used polyclonal anti-
bodies against a signature apicoplast protein, acyl carrier
protein (ACP; Friesen et al., 2010), and co-stained ﬁxed
PALM-mCherry-myc parasite-infected hepatocytes with
monoclonal anti-myc antibody (Fig. 4A). The staining
overlapped substantially, strongly suggesting that tagged
PALM is indeed transported efficiently into the apicoplast.
In apicomplexan parasites, the apicoplast and the mito-
chondrion are in close association (Tonkin et al., 2004),
necessitating additional proof for an exclusive localization
to one of the two organelles. Previous work established
that antibiotic treatment during liver-stage development
abrogated apicoplast growth and segregation (Friesen
et al., 2010). We therefore repeated the immunolocaliza-
tion experiment in the presence or absence of 1 mM
azithromycin (Fig. 4B–D). Destruction of the apicoplast
integrity by this treatment abolished the ACP- and PALM-
positive branched structure and, instead, limited the
signal to a small peripheral dot. Together, our data show
that PALM is expressed in blood-stage schizonts,
throughout the parasite’s mosquito stage development,
and, most abundantly, during liver-stage development. In
all stages, PALM localizes to the apicoplast of the devel-
oping parasite.
Blood and mosquito stage development of palm-
parasites is unaffected
Our analysis in conjunction with available PALM expres-
sion data suggested a minor role during replication of
asexual blood stages. We therefore attempted to ablate
PALM by targeted gene deletion using a replacement
strategy through homologous recombination (Fig. 5A).
After transfection of wild-type ANKA strain parasites and
positive selection, the recombinant parental parasite
population was genotyped (Fig. 5B). Replacement-
speciﬁc PCR products indicated successful deletion of
PALM in our recombinant parental parasite population.
Fig. 2. Live cell imaging of PALM in infected hepatoma cells.
A. Generation of PALM-mCherry-myc parasites. The PbPALM genomic locus was targeted with a replacement plasmid containing the
C-terminal PALM fragment (grey) fused in-frame to the mCherry coding sequence (red), and a quadruple c-myc tag (blue) and followed by the
3′UTR of PbDHFS/FPGS. In addition, the targeting plasmid contains the PbDHFR/TS positive selectable marker (black box), and a fragment
of the PALM 3′UTR. Upon a double cross-over event, the targeting plasmid is expected to replace the endogenous PALM ORF with a
C-terminally tagged PALM fusion protein. Arrows and bars indicate speciﬁc primers and PCR fragments respectively.
B. Genotyping of the PALM-mCherry-myc parasite line. Using integration-speciﬁc primer combinations (A), the successful replacement event
was veriﬁed. Absence of the WT signal from PALM-mCherry-myc parasites conﬁrmed the purity of the clonal population.
C. Hepatoma cells were infected with PALM-mCherry-myc sporozoites. PALM expression was visualized in late liver stages 2 days after
infection. Note the branched structure of the mCherry signal. Bars, 10 mm.
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during Plasmodium life cycle progression, we ﬁrst tested
the mixed parental population, containing both ANKA wild
type and palm - ANKA parasites, in a mouse-mosquito-
mouse passage (Fig. 5B). Only ANKA parasites were
detectable after completion of the life cycle, suggestive of
a vital role at some point during transmission between
mammalian hosts.
To systematically characterize PALM loss-of-function
parasites, we generated two additional, independent
mutant parasites that lack PALM. To generate the second
palm - Iine, we used the same targeting vector as above
(Fig. 5A) but transfected ﬂuorescent parasites, so-called
ANKA-GFP parasites (Janse et al., 2006). The resulting
parasites were labelled palm -ANKA-GFP. In a third trans-
fection experiment, we used a slightly modiﬁed targeting
vector that was predicted to replace PALM with a fusion
protein of the N-terminal PALM apicoplast targeting
sequence to the red ﬂuorescent protein mCherry and a
quadruple myc-tag (Fig. 5C). This line, termed palm --NT-
tag, represents a functional gene knockout and a target-
ing reporter construct, simultaneously.
Fig. 3. Expression of PALM during the Plasmodium berghei life
cycle. PALM-mCherry-myc parasites were used to infect mice and
Anopheles stephensi mosquitoes. Intra- and extracellular parasite
stages were ﬁxed, permeabilized and stained with mouse anti-myc
antibody (red). In replicating stages, nuclei were stained with the
DNA-dye DRAQ5 (blue). The GFP signal in ﬁxed sporozoites was
used to display the extracellular parasite.
A. Blood-stage schizont (BS schizont) from an infected mouse.
Note that the anti-myc signal is very weak and was only detectable
after background subtraction in comparison with WT
parasite-infected erythrocytes. Bars, 5 mm.
B. Oocysts ﬁxed at day 10 after infection. Bars, 10 mm.
C. Salivary gland sporozoites ﬁxed at day 17 after infection. Bars,
10 mm.
D. Liver-stage parasites ﬁxed at 48 h after infection of hepatoma
cells. Bars, 10 mm. Note the branched structure indicative of an
apicoplast localization of PALM.
Fig. 4. Apicoplast localization of PALM.
A. Co-staining of ﬁxed, PALM-mCherry-myc parasite-infected
hepatoma cells 48 h after infection using anti-myc and anti-ACP
antibodies. Note the substantial overlap between PALM and the
signature apicoplast protein.
B. PALM-mCherry-myc parasite-infected hepatoma cells left
untreated, ﬁxed at 48 h after infection, and stained with antibodies
speciﬁc for the myc epitope and upregulated in infectious
sporozoites protein 4 (UIS4), a signature protein of the
parasitophorous vacuole. Note the branched PALM-positive
structures.
C. Antibiotics treatment with 1 mM azithromycin abolishes the
branched PALM-positive structures while parasites appear to
remain healthy otherwise.
D. Antibiotics treatment with 1 mM azithromycin abolishes the
branched PALM-positive structures as well as ACP-positive
structures. All bars, 10 mm.
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generated clonal palm - parasite lines by in vivo cloning
through limited dilution. Genotyping revealed the pres-
ence of the predicted integration events (Fig. 5D and E).
In the following sections, the majority of the presented
data were generated using the palm - ANKA-GFP line.
This was possible, as careful phenotyping of the three
independent palm - lines revealed identical behaviour
under all assay conditions (Table S1), indicating that the
results obtained from one line can be attributed directly to
loss of PALM function.
Successful ablation of the PALM gene in asexual blood
stages already indicated a dispensable role during the
pathogenic phase of the Plasmodium life cycle. Indeed,
Fig. 5. Generation of palm
- parasites.
A. The PbPALM genomic locus was targeted with a replacement plasmid containing PALM 5′ and 3′ fragments (thick black lines) and the
DHFR/TS positive selectable marker (black box). Upon a double cross-over event, the targeting plasmid is expected to replace the
endogenous PALM ORF. Arrows and light grey solid lines indicate speciﬁc primers and PCR fragments respectively. Black bars indicate
speciﬁc 5′ and 3′ probes; dark grey dashed lines represent EcoRI or KpnI restriction-digested fragments of WT or knockout parasite gDNA.
B. Mouse-mosquito-mouse transmission experiment starting from a mixed WT/palm
- infection (input) and resulting in a pure WT population
after completion of one transmission cycle (output). Parasites were genotyped by PCR using wild-type (WT)- and replacement (INT)-speciﬁc
primer pairs, as indicated in (A).
C. Alternative gene replacement vector to ablate the PALM locus. The PbPALM genomic locus was targeted with a replacement plasmid
containing a PALM 5′ fragment, containing a portion of the PALM open reading frame (grey box), fused to the mCherry protein (red box) and
quadruple myc tag (blue box), followed by the DHFR/TS positive selectable marker (black box) and the 3′ ﬂanking region (thick bar). Upon a
double cross-over event, the targeting plasmid is expected to replace the endogenous PALM ORF. Arrows and bars indicate speciﬁc primers
and PCR fragments respectively.
D. Genotyping of the palm
- ANKA-GFP parasite line used for the majority of experiments through Southern blot analysis. Probes at the 5′ and
3′ UTR of PALM were used to demonstrate the expected size shift of restriction-digested gDNA of WT and knockout parasites.
E. Genotyping of the three clonal palm
- parasite lines obtained from independent transfection experiments. Using integration-speciﬁc primer
combinations (A, C) the successful replacement event (INT) was veriﬁed. Absence of the WT signal from palm
- parasites conﬁrmed the purity
of the clonal populations. The clonal populations palm
- ANKA (blue) and palm
- ANKA-GFP (green) were obtained according to design (A),
using WT-ANKA and ANKA-GFP parasites as recipient lines (left); the clonal population palm
--NT-tag (red) was obtained according to design
(C), using ANKA-GFP parasites as recipient lines (right).
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difference compared with ANKA-GFP parasites and
reached equally high parasitaemia levels in infected mice
(Fig. S1A).
We next transmitted all three palm - clones and the
PALM-mCherry-myc parasites, as an additional WT-like
reference line, to the mosquito vector and followed
sporogony in the female Anopheles host (Fig. S1 and
Table S1). Compared with ANKA-GFP parasites, no dif-
ferences in numbers of either infected mosquitoes
(Fig. S1B) or sporozoites in the mosquito midguts or sali-
vary glands were detectable (Fig. S1C). In conclusion,
PALM is dispensable for Plasmodium blood-stage devel-
opment, transmission to the mosquito vector, and
sporogony in the invertebrate host.
palm- parasites are severely impaired in initiation of a
blood-stage infection
Normal colonization of the Anopheles salivary glands
(Fig. S1C) permitted mosquito-to-mouse transmission
experiments. When we fed ﬁve infected mosquitoes on
naïve C57BL/6 mice, ~50% of mice bitten by palm - GFP-
ANKA-infected mosquitoes remained completely malaria-
free, while the other half showed a severe delay in
patency ranging from 3 to 8 days (Fig. 6A).
We next inoculated ANKA-GFP or palm - sporozoites
into C57BL/6 mice by intravenous injection of increasing
doses and monitored the occurrence of blood-stage para-
sites (Fig. 6B). All mice injected with ANKA-GFP sporo-
zoites became patent on day 3 after infection. In sharp
contrast, patency of mice injected with sporozoites of
either of the three palm - lines was severely delayed by at
least 4 days. In the rodent malaria model system, a delay
of 1 day in patency corresponds to a 10-fold reduction in
initial asexual blood-stage parasite load. Most importantly,
a large proportion (~70%) of mice remained entirely
malaria-free at day 17 after infection (Fig. 6B). This pre-
erythrocytic in vivo defect explains the initial observation,
Fig. 6. Infection with palm
- sporozoites leads to attenuated
liver-stage development in vivo.
A. Kaplan–Meier analysis of time to malaria blood-stage infection.
C57BL/6 mice were infected by natural bite with ﬁve mosquitoes
infected with ANKA-GFP (grey, n = 11) or palm
- ANKA-GFP (black,
n = 13). Animals were monitored daily for presence of parasites in
Giemsa-stained blood smears.
B. Kaplan–Meier analysis of time to malaria blood-stage infection.
C57BL/6 mice were infected with 1000, 10 000, or 100 000
ANKA-GFP (blue, n = 3, 9, 3) or palm
- ANKA-GFP (red, n = 20, 82,
45) sporozoites by intravenous injection. Animals were monitored
daily for presence of parasites in Giemsa-stained blood smears.
C. Development of symptoms of ECM is only reduced in palm
-
sporozoite-infected animals. Shown is the percentage of
parasite-positive C57BL/6 mice that develop signature symptoms of
ECM (i.e. mice showing sudden onset of ataxia, paralysis,
convulsion or coma, or a minimum of three behavioural and
functional abnormalities) after injection of 1000 blood-stage
parasites (ANKA-GFP, grey, n = 15; palm
- ANKA-GFP, black,
n = 15), injection of sporozoites [10 000 ANKA-GFP, grey, n = 9;
palm
- ANKA-GFP, black, 1000 (n = 6), 10 000 (n = 20), or 100 000
(n = 13)], or infection by natural bite with ﬁve mosquitoes infected
with ANKA-GFP (grey, n = 11) or palm
- ANKA-GFP (black, n = 13).
D. Integrity of the blood–brain barrier is preserved in most palm
-
sporozoite-infected mice. Mice were infected with 10 000
ANKA-GFP sporozoites (n = 4), or 10 000 (n = 5) or 100 000 (n = 7)
palm
- ANKA-GFP sporozoites. Evan’s blue was injected
intravenously at day 4 after appearance of blood-stage parasites
and brains removed for documentation. One mouse infected with
100 000 palm
- ANKA-GFP sporozoites showed behavioural
abnormalities and breakdown of the blood–brain barrier.
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the life cycle (Fig. 5B).
Irrespective of the molecular role of PALM, the mutant
parasite lines are valuable tools to address two important
questions in malaria research. First, does a prolonged
pre-erythrocytic phase inﬂuence the clinical outcome of
a sporozoite-induced infection? This problem can be
addressed by analysing the mice that become blood-
stage-positive (Fig. 6B; population ‘+’). Second, does
immunization with palm - sporozoites induce protection
against reinfection? This question can be addressed by
boosting the mice that stay malaria-free (Fig. 6B; popula-
tion ‘-’) with additional palm - sporozoites, followed by WT
challenge infections.
Impaired liver-stage development leads to reduced
incidence of experimental cerebral malaria (ECM)
We ﬁrst followed the clinical symptoms of population ‘+’,
i.e. those mice that became palm - blood-stage-positive
(Fig. 6C). Only few palm --infected mice developed symp-
toms of ECM, a fatal outcome of an acute Plasmodium
infection, as compared with ANKA-GFP-infected animals.
Signature signs of ECM are sudden onset of ataxia,
paralysis, convulsion or coma (de Souza et al., 2010).
Symptoms of ECM typically develop on the fourth day
after patency in sporozoite-induced infections. Of note,
none of the mice that were infected by bite of palm --
infected mosquitoes developed ECM.
It is important to exclude any impairment in parasite
virulence due to the genetic manipulation. We previously
detected normal blood-stage parasite growth (Fig. S1A).
To conﬁrm that palm- parasites are as virulent as WT
parasites; we inoculated 1000 erythrocytes infected with
either palm - ANKA-GFP or, as controls, ANKA-GFP
parasites via blood transfusion, thus bypassing the liver
merozoite phase (Fig. 6C). All animals developed the sig-
nature ECM symptoms and had to be carefully culled to
avoid unnecessary suffering. Therefore, the reduced ECM
incidence of palm --infected mice can be entirely attrib-
uted to the altered pre-erythrocytic development of these
parasites.
We ﬁnally determined the integrity of the blood–brain
barrier in sporozoite-injected animals by Evan’s blue stain
at the peak of clinical symptoms in WT-infected animals,
typicallyday4afterpatency(Fig. 6D).Thisanalysisfurther
corroborated the strongly reduced cases and severity of
ECM-related pathology in the palm --positive mice.
Immunization with palm- parasites induces potent
protection against reinfection
We next tested whether booster immunization with palm -
parasites could confer protection against sporozoite chal-
lenge in population ‘-’ (Table 1). Extensive previous work
with either irradiated sporozoites or genetically arrested
parasites showed that in the P. berghei-C57BL/6 model
three consecutive doses of attenuated parasites are
needed to induce sterile immunity (Nussenzweig et al.,
1967; Mueller et al., 2005b; Douradinha et al., 2007). In
addition, two studies reported sterile protection of between
25%and70%ofmiceupto10daysfollowingimmunization
using two immunizations (van Dijk et al., 2005; Mueller
et al., 2005a).
Anticipating comparable levels of protection using three
immunization rounds, we directly attempted a two-dose
immunization protocol, with 10 000 palm - ANKA-GFP
sporozoites each (Table 1). Intriguingly, this immunization
protocol elicited sterile protection in all mice against
both intravenous sporozoite challenge and naturally trans-
Table 1. Immunization with palm
- sporozoites confers potent protection against reinfection.
Challenge palm
- immunization
a # Protected/# Challenged
b Prepatency (days)
c
Exposure to ﬁve infected mosquitoes 2 ¥ 10 000 spz 20/20 (100%) –
2 ¥ 1000 spz 0/2 (0%) 6.0
naïve 0/10 (0%)
d 4.0
Intravenous injection of 10 000 sporozoites 2 ¥ 10 000 spz 5/5 (100%) –
naïve 0/6 (0%) 3.0
Intravenous injection of 10 000 sporozoites (day 110)
e 2 ¥ 10 000 spz 6/7 (86%) 8.0
naïve 0/3 (0%) 3.0
Intravenous injection of 10 blood-stage parasites
f 2 ¥ 10 000 spz 0/4 (0%) 6.0
naïve 0/5 (0%) 6.0
a. Age-matched female C57BL/6 mice were immunized with palm
- sporozoites (spz) in the numbers indicated. The immunization protocol is
described in the Experimental procedures section.
b. Animals were checked for parasitaemia by daily examination of Giemsa-stained blood smears.
c. Prepatency is the time until detection of the ﬁrst parasite in the peripheral blood.
d. One additional naïve mouse (not included) stayed initially malaria-free but became positive at day 3 after intravenous re-challenge.
e. Challenge at 110 days after the last immunization.
f. The immunized mice were previously shown to be fully protected against ‘by bite’ challenge.
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Even after a period of more than 100 days, six of seven
mice were completely protected from reinfection following
an initial challenge of 10 000 intravenously injectedANKA-
GFP sporozoites. The single mouse that developed a
blood-stage malaria infection showed a substantial delay
in patency of 5 days, suggestive of the presence of strong
pre-erythrocytic immunity, and did not develop any ECM-
associated symptoms. When we reduced the immuniza-
tions to two doses of 1000 sporozoites sterilizing immunity
and protection development of signs of ECM was lost but
infections became patent with a 2 day delay, indicative of a
substantial degree of protective immune responses.
We also re-challenged four mice that had previously
been immunized twice with 10 000 palm - ANKA-GFP
sporozoites and challenged by ANKA-GFP-infected mos-
quito bites with ten ANKA-GFP blood-stage parasites. We
observed no protection or delay in prepatency in compari-
son with naïve control mice (Table 1). Together, these
ﬁndings demonstrate that palm - genetically arrested para-
sites can elicit potent protective liver stage-speciﬁc
immune responses against reinfection with as few as two
immunization doses.
palm- parasites form liver schizonts in vitro
The severe impairment of pre-erythrocytic development in
vivo together with the unprecedented potent protection
obtained by immunization with palm - genetically arrested
parasites prompted us to analyse the precise develop-
mental arrest of these parasites in vitro. We ﬁrst moni-
tored intra-hepatic parasite growth in cultured hepatoma
cells (Fig. 7A). Quantiﬁcation of liver-stage parasites
revealed no differences at 24 and 48 h after infection.
Interestingly, we noticed the presence of high numbers of
palm - liver-stage parasites at 72 h after infection, when
ANKA-GFP and PALM-mCherry-myc parasites have typi-
cally formed merosomes and egressed from the host cells
(Fig. 7A). Apparently, more than two-thirds of palm - para-
sites remain intracellular, whereas this is true for less than
one-third of ANKA-GFP parasites. This ﬁnding offered a
ﬁrst potential explanation for the observed deﬁciency of
palm - parasites to complete a full life cycle (Fig. 5B).
At this point, we also wanted to further conﬁrm the
absence of PALM transcripts in the palm - ANKA-GFP
parasites by RT-PCR, as late liver stages display the most
abundant PALM transcription in WT parasites. To this end,
we harvested livers from WT- and palm --infected mice
44 h after infection and performed RT-PCR on the isolated
RNA (Fig. 7B). Absence of PALM-speciﬁc transcripts
further conﬁrmed the successful ablation of the gene,
while a signature gene of mammalian parasite stages,
HSP70, was readily detectable in all livers of either WT- or
palm --infected animals.
We next harvested and quantiﬁed liver merozoite-
containing vesicles, termed merosomes, from infected
hepatoma cells (Fig. 7C). In contrast to ANKA-GFP
parasite-infected cells, we repeatedly failed to obtain sub-
stantial merosome numbers from palm --infected cells.
However, when injected intravenously into naïve NMRI
mice, palm - ANKA-GFP merosomes were fully infectious
and all inoculated mice became eventually malaria-
positive (Fig. 7D).
To test whether the apicoplast, the organelle harbour-
ing PALM, is affected by PALM ablation, we stained
hepatoma cells with PALM-mCherry-myc and palm - para-
sites 48 h after sporozoite addition with anti-ACP antibod-
ies (Fig. 7E). As exempliﬁed for the palm --NT-tag line,
mutant liver stages showed no obvious difference when
compared with the transgenic control, i.e. PALM-mCherry-
myc. We conclude that late liver stages appear normal in
palm - parasites.
palm- parasites display a defect in liver merozoite
formation in vitro
We wanted to characterize the apparent late developmen-
tal arrest further and, therefore, stained ANKA-GFP and
palm - ANKA-GFP parasites during liver-stage develop-
ment with antibodies against two signature proteins:
upregulated in infectious sporozoites protein 4 (UIS4),
which localizes to the parasitophorous vacuole (Mueller
et al., 2005b), and the major merozoite surface protein 1
(MSP1; Holder and Freeman, 1981) (Fig. 8A). In good
agreement with successful liver-stage growth (Fig. 7A),
ANKA-GFP and palm - ANKA-GFP were indistinguishable
at 24 and 48 h after infection. At this point in parasite
development, ANKA-GFP and palm - ANKA-GFP para-
sites commence MSP1 expression with the protein prima-
rily located to the rim of the developing schizont.
We noticed striking differences when we monitored
merozoite formation. Despite normal development until
late liver stages, very few palm - ANKA-GFP parasites
formed merozoites compared with ANKA-GFP parasites
(Fig. 8B). At this stage, and even more pronounced at
94 h after infection, numerous palm - ANKA-GFP para-
sites show MSP1 staining outside the parasitophorous
vacuole. We conclude that in the absence of PALM mero-
zoite segregation is aborted. Together, these ﬁndings
demonstrate a distinct and important role of PALM in full
maturation of liver merozoites. In the absence of PALM,
efficient formation of liver merozoites is the limiting step in
Plasmodium life cycle progression.
Discussion
In this study, we characterized a novel apicoplast targeted
protein of the malaria parasite with an important function
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modium apicoplast protein important for liver merozoite
formation’ (PALM). PALM loss-of-function parasites retain
their capacity to infect and mature inside hepatocytes.
However, towards the ﬁnal steps of merozoite segrega-
tion, palm - parasites display a strong impairment, result-
ing in a severe delay in sporozoite-induced blood-stage
infections.
Towards the function of PALM
Unlike several genetically arrested parasites deﬁcient in
apicoplast-targeted proteins of the FASII pathway (Yu
et al., 2008; Vaughan et al., 2009; Pei et al., 2010), palm -
parasites develop to a much later time point, as indicated
by the expression of the merozoite signature protein
MSP1. In this study, we were able to deﬁne many key
features of this previously unrecognized protein, including
the subcellular localization, the life cycle stages at which
PALM is expressed, and the critical time point of PALM
activity. What could be the molecular function during the
process of merozoite formation?
Many proteins imported into the apicoplast perform
metabolic functions in one or more of the key processes
assigned to this enigmatic organelle. Indeed, applying a
recently developed extended similarity group method
(Chitale et al., 2009), P. falciparum PALM is predicted to
display potential transferase activity of uncertain speciﬁc-
ity, which may be attributed to the conserved domain with
the invariant cysteine residues (Fig. 1). However, it is
equally conceivable that the cysteine pair fulﬁls structural
or other roles.
Fig. 7. palm
- parasites display a defect in liver-stage maturation.
A. Quantiﬁcation of liver stages in cultured hepatoma cells at 24, 48 and 72 h after infection with 10 000 P. berghei ANKA-GFP and palm
-
ANKA-GFP sporozoites. Infected cells were ﬁxed and stained with mouse anti-PbHSP70 antibodies. Note that in contrast to ANKA-GFP
parasites, palm
- ANKA-GFP parasites remain inside the host cells even at 72 h after infection. Data are from two independent experiments
done in triplicate. Shown are mean numbers ( SD).
B. Parasite transcript detection in WT and palm
- parasite-infected livers conﬁrms the successful ablation of PALM in the knockout line. cDNA
was prepared from liver homogenates extracted from mice at 44 h after sporozoite infection. Quality of cDNA preparations and presence of
parasites in vivo was controlled using HSP70-speciﬁc primers.
C. Defect of merosome formation in palm
- parasites. Quantiﬁcation of merosomes obtained from cultured hepatoma cells infected with
ANKA-GFP and palm
- ANKA-GFP parasites at 72 h after inoculation with 100 000 sporozoites.
D. palm
- ANKA-GFP merosomes are infectious to mice. Complete merosome containing supernatants harvested under (C) were injected into
recipient C57BL/6 mice (ANKA-GFP, n = 5; palm
-, n = 4) and monitored for malaria infections by examination of Giemsa-stained
blood-smears.
E. Apicoplast morphology appears normal in palm
- liver stages. Hepatoma cells infected with WT and palm
- parasites were ﬁxed at 48 or
60 h after infection and stained for parasite cytoplasm and the apicoplast using anti-HSP70 and anti-ACP antibodies respectively. The merge
includes an additional DRAQ5 nuclear stain. Bars, 10 mm.
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opment in comparison with FASII pathway mutants, a
metabolic role in the biogenesis of fatty acids is unlikely.
Development of biochemical assays and metabolome pro-
ﬁling, which have not been achieved yet in Plasmodium-
infected liver cells, would be needed to support this rather
speculative prediction.Apuzzling question is why PALM is
not equally important for other Plasmodium life cycle
stages, in particular in blood-stage schizonts and during
mosquito midgut sporozoite formation, where we have
clearly demonstrated the presence of the myc-tagged
PALM protein.
Staining of developing liver-stage palm - parasites with
antibodies against a signature apicoplast-targeted protein
(ACP) demonstrated that apicoplast growth, branching
and protein import of ACP are unaffected in the absence
of PALM. We can, therefore, reject the hypothesis that
PALM is involved in the process of apicoplast segregation
itself. This is plausible, because of the observed expres-
sion of PALM in blood-stage schizonts and mosquito
stage midgut oocysts and the apparent absence of PALM
orthologues in other obligate intracellular parasites of the
phylum Apicomplexa.
The strictly liver stage-speciﬁc role of PALM in vivo is
further supported by the differential clinical outcome of a
blood stage-induced vs. a sporozoite-induced infection.
We can exclude a detectable in vivo role of PALM during
blood-stage replication, which in the P. berghei ANKA-
C57BL/6 mouse model leads to a uniform fatal outcome.
An intriguing possibility is that PALM emerged in
response to speciﬁc requirements for the development
of malaria parasites in hepatocytes. Because pre-
erythrocytic development of avian malaria species, such
as Plasmodium gallinaceum, does not occur in hepato-
cytes but rather in cells of the mononuclear phagocyte
Fig. 8. palm
- parasites cannot ﬁnalize liver merozoite formation
efficiently.
A. Defect in liver-stage merozoite segregation in palm
- parasites.
In vitro cultured P. berghei ANKA-GFP and palm
- ANKA-GFP liver
stages, were ﬁxed at various time points after sporozoite infection
and visualized by immunoﬂuorescence using monoclonal mouse
anti-P. yoelii MSP1 and rabbit anti-P. berghei UIS4 antibodies.
Nuclei were stained with the DNA-dye DRAQ5 (blue). palm
-
ANKA-GFP parasites develop normally until late liver stages but
rarely form merozoites. Shown are representative images of
ANKA-GFP and palm
- ANKA-GFP at various time points. Bars,
10 mm.
B. Quantiﬁcation of productive liver merozoite formation. Liver
stages from ANKA-GFP and palm
- ANKA-GFP parasites were
scored at 48, 60 and 72 h after infection (ANKA-GFP n = 105, 94,
82; palm
- n = 99, 124, 107) according to the ﬁve categories
indicated by the representative images in the inset. The categories
are: no MSP1 (white), rim staining of MSP1 (light green),
intracellular schizont staining of MSP1 (dark green), formation of
MSP1-positive merozoites (yellow), and aberrant, external MSP1
staining (black). Note the high proportion of MSP1-positive
schizonts in palm
- parasites, which correlates with a low production
of MSP1-positive pathogenic merozoites.
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In the absence of complete genome sequences of avian
Plasmodium species, cloning and sequencing of the
orthologous region should reveal whether P. gallinaceum
harbours a PALM orthologue or not. The sheer number of
merozoites being produced during the pre-erythrocytic
phase may require a yet unidentiﬁed synthetic pathway in
the apicoplast that is dispensable for other life cycle
stages and related apicomplexan parasites.
Delayed pre-erythrocytic development is beneﬁcial for
the clinical outcome
Intriguingly, a substantial proportion of those animals
infected with palm - sporozoites and developing blood-
stage parasitaemia do not develop ECM. This ﬁnding is
reminiscent of the consistent ﬁndings seen in phase II
clinical trials with the RTS,S vaccine (Guinovart et al.,
2009; Moorthy and Ballou, 2009). Efficacy of this anti-
sporozoite subunit vaccine was particularly robust against
severe malaria as endpoint. It was proposed that partial
pre-erythrocytic protection, as seen in RTS,S, might trans-
late into sustained asexual stage protection through
leakage of low-dose parasites (Guinovart et al., 2009).
The palm - parasites in combination with C57BL/6 mice
permit a detailed immunological analysis of a potential link
between clinical outcome and the time to emergence and
inoculum size of liver-stage merozoites. Therefore, the
generation of a potent, yet leaky, late liver stage arrested
vaccine line may recapitulate key ﬁndings of the candi-
date malaria vaccine RTS,S/AS, which is tested in phase
III clinical trials (Cohen et al., 2010). The demonstration of
normal virulence by transfusion-mediated infection with
palm - parasites (Fig. 6C) excludes a direct role of PALM
in ECM. Instead, we consider it likely that a prolonged
liver-stage infection resulting in a particularly slow onset
of blood-stage infection inﬂuences the host defence and
provides an advantage that prevents the development of
ECM symptoms.
Development of second-generation genetically
arrested parasites
As exempliﬁed by the generation of the palm - parasites, a
tailor-made genetic arrest in liver-to-blood-stage conver-
sion has the potential to elicit potent protective immune
responses against future malaria infections. We employed
the P. berghei-C57BL/6 model, because it is the most
stringent rodent malaria model, i.e. the most difficult to
protect against (Ngonseu et al., 1998; Doolan and
Hoffman, 2000). Complete sterilizing immunity protecting
all immunized animals by only two doses of genetically
arrested P. berghei parasites is unprecedented thus far.
Two studies have reported protection in a fraction of mice
by two consecutive immunizations (van Dijk et al., 2005;
Mueller et al., 2005a). In addition to incomplete protec-
tion, in both cases challenges were performed already
after 7 or 10 days following the ﬁnal boost, and in one
case the immunization doses were also substantially
higher. So far, there is just a single study describing long-
term protection of 118 days using the P. berghei-C57BL/6
model with genetically arrested Pbuis3 -/uis4 - parasites
(Jobe et al., 2007). The protocol employed three subse-
quent immunization rounds and it is unclear, but unlikely
in the light of incomplete short-term protection acquired
using uis4 - parasites, that a single booster would suffice.
Development of experimental immunization protocols with
lower and fewer doses is particularly important in the
context of integrating a safe, affordable and accessible
malaria vaccine into the expanded programme of immu-
nization for infants. Although still elusive, such a vaccine
should ideally have the capacity to induce potent immune
responses after as few postnatal care visits as possible.
It is tempting to speculate that inclusion of additional
late liver-stage antigens, such as shown here for abun-
dant expression of MSP1 in palm - parasites, in a whole-
organism vaccine line may elicit superior immune
responses, i.e. lasting protection with fewer and/or lower
vaccine doses. There is precedence for potent short- and
long-term protection by delivery of low-dose sporozoite
inocula under chloroquine cover (Roestenberg et al.,
2009; 2011). These results indicate that advanced liver-
stage development may correlate with more potent
immune responses. This notion is supported by a subunit
vaccine strategy using viral vaccine vectors that express
one of several PyMSP1 fragments (Draper et al., 2009).
Immunization induced CD8+ T-cell responses that corre-
lated with partial anti-liver-stage protection in the Plasmo-
dium yoelii-BALB/c model. Our ﬁndings suggest that
generation of a safe, MSP1-positive, genetically arrested
parasite line may be an important improvement over ﬁrst
generations, which are arrested during onset of liver-
stage development. Due to substantial breakthrough
infections (Fig. 6B), direct translation of palm - parasites
as genetically arrested parasites for human vaccine trials
is currently not possible. However, additional gene dele-
tions that affect late liver-stage parasite development in
the palm - background could be used to generate a safe
synthetic late-stage arrested parasite.
In conclusion, we describe a previously uncharacter-
ized protein, PALM, which localizes to the apicoplast. We
show that PALM plays an important role during the ﬁnal
stages of hepatic merozoite maturation and is required for
the efficient transition to a blood-stage infection. Genetic
arrest in stage conversion from completion of clinically
silent development inside the host liver to pathogenic
asexual blood stages has the potential to elicit potent
protection against reinfections.
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Experimental animals
This study was carried out in strict accordance with the
German ‘Tierschutzgesetz in der Fassung vom 22. Juli 2009’
and the Directive 2010/63/EU of the European Parliament
and Council ‘On the protection of animals used for scientiﬁc
purposes’. The protocol was approved by the ethics commit-
tee of the Berlin state authority (‘Landesamt für Gesundheit
und Soziales Berlin’, permit number G0469/09). C57BL/6
mice were used for sporozoite challenges and analysis of
ECM. All other parasite infections were conducted in NMRI
mice, unless otherwise indicated.
Generation of PALM-mCherry-myc and palm- parasites
Mutant parasites were generated as described previously
(Janse et al., 2006). See supporting experimental procedures
and Table S2 for further details on transfection vector con-
struction and conﬁrmation of successful transfection.
Plasmodium mosquito stage development
Anopheles stephensi mosquitoes were raised under a 14 h
light/10 h dark cycle at 28°C and 75% humidity. Blood-
feeding and mosquito dissection were performed as
described previously (Vanderberg, 1975). In order to deter-
mine infectivity, and quantify midgut and salivary gland asso-
ciated sporozoites, infected mosquitoes were dissected at
days 10, 14 and 17 after feeding respectively.
Midguts of PALM-mCherry-myc infected mosquitoes were
dissected at day 10 and ﬁxed with 4% paraformaldehyde
with 0.0075% glutaraldehyde. Subsequently, midguts were
permeabilized with 0.5% Triton X-100 and blocked with 3%
bovine serum albumin. Incubation with mouse anti-myc
antibodies (1:200 dilution, Santa Cruz Biotechnology) was
done overnight at 4°C. Bound antibodies were detected
using donkey anti-mouse IgG Alexa Fluor 488 conjugated
antibodies (1:2000 dilution, Invitrogen). Nuclei were visual-
ized with the DNA-dye DRAQ5 (1:1000 dilution, Axxora)
and coverslips were mounted with Fluoromount-G (South-
ern Biotech).
Salivary glands of PALM-mCherry-myc infected mosqui-
toes were dissected and liberated sporozoites were settled
in RPMI medium containing 3% bovine serum albumin and
ﬁxed with 4% paraformaldehyde. Subsequently, sporozoites
were permeabilized with 0.1% Triton X-100 in PBS and
blocked with 3% bovine serum albumin. Incubation with
mouse anti-myc antibodies (1:100 dilution, Santa Cruz Bio-
technology) was done overnight at 4°C. Bound antibodies
were detected using donkey anti-mouse IgG Alexa Fluor
546 conjugated antibodies (1:1000 dilution, Invitrogen).
Coverslips were mounted with Fluoromount-G (Southern
Biotech).
To determine sporozoite infectivity to mice, sporozoites
collected from mosquito salivary glands were injected intra-
venously at the numbers indicated into C57BL/6 mice.
Patency was determined by examination of daily Giemsa-
stained thin blood smears.
Phenotyping of Plasmodium life cycle progression
Plasmodium berghei mosquito stages were maintained and
analysed using standard techniques (Vanderberg, 1975).
During all experiments, mice were monitored for the devel-
opment of behavioural and functional abnormalities (Lackner
et al., 2006), as indicators of ECM development. Mice were
classiﬁed as suffering from ECM when they were diagnosed
with at least three behavioural and functional abnormalities
(e.g. positional passivity, body position, limb grasping, toe
pinch, etc.). Mice were immediately sacriﬁced upon showing
sudden onset of signature symptoms of ECM, such as ataxia,
paralysis, convulsions or coma. To test the integrity of the
blood–brain barrier as a further indication for the susceptibil-
ity to ECM, we injected 100 ml of 2% Evans Blue in saline
i.v. into naïve C57BL/6 mice, or mice infected with 10 000
or 100 000 palm
-, or 10 000 ANKA-GFP sporozoites at day 4
after patency. After 1 h, mice were sacriﬁced, brains pre-
pared, and digital images taken using standardized lighting,
exposure and white balance settings.
Plasmodium liver-stage development in cultured
hepatoma cells
Plasmodium berghei in vitro liver stages were cultured and
analysed using standard techniques (Silvie et al., 2008b). In
short, 30 000 hepatoma (HuH7) cells per well were plated in
eight-well chamber slides (Nalge Nunc International). After
24 h the cells were incubated with 10 000 sporozoites, ﬁrst
for 60 min at room temperature, then at 37°C for 90–120 min.
Non-invaded sporozoites were washed off and medium
was changed daily. At the time points indicated, infected
hepatoma cultures were ﬁxed for 10 min with ice-cold metha-
nol and blocked with PBS/10% FCS.
For conﬁrmation of expression, liver-stage PALM-mCherry-
myc parasites were ﬁxed and incubated with mouse anti-myc
antibodies (1:1000 dilution, Santa Cruz Biotechnology). To
conﬁrm apicoplast targeting of PALM, liver-stage parasites
were co-stained with rabbit anti-P. berghei ACP peptide anti-
serum(1:750dilution;Friesenet al.,2010).Completionofliver
merozoite formation was analysed using rabbit anti-P. berghei
upregulated in infectious sporozoites protein 4 (UIS4) peptide
antiserum (1:2000 dilution; kindly provided by G. Montagna,
MPI-IB, Berlin) and a monoclonal mouse anti-P. yoelii mero-
zoite surface protein 1 (MSP1) antibody against a 90 kDa
N-terminal fragment of the protein that shares 74% identity
with P. berghei MSP1 (1:2000 dilution; kindly provided by T.
Holder, National Institute for Medical Research, London, UK).
Liver-stage parasites were visualized and quantiﬁed using
monoclonal mouse anti-P. berghei heat shock protein 70
(HSP70) antibodies (1:300 dilution; Tsuji et al., 1994). Bound
antibodies were detected using donkey anti-rabbit/mouse IgG
Alexa Fluor 488/546 conjugated antibodies (1:3000 dilution,
Invitrogen). Nuclei were visualized with DNA-dyes Hoechst
33342 (Invitrogen) and DRAQ5 (Axxora; both 1:1000 dilution)
and coverslips were mounted with Fluoromount-G (Southern
Biotech). Images were recorded using a Leica TCS SP-1
confocal microscope. Total numbers of parasites were
counted using a Leica DM2500 epiﬂuorescence microscope.
To conﬁrm the apicoplast localization of PALM, we used
1 mM azithromycin (Pﬁzer) treatment of sporozoite-infected
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2010).
Merosome formation was followed using two different
methods, either by (i) seeding of 100 000 to 150 000
hepatoma cells per well in 24-well plates and inoculation with
100 000 sporozoites per well 24 h later, or by (ii) seeding of
30 000 hepatoma cells per well in eight-well chamber slides
(Nalge Nunc International) and inoculation with 10 000 sporo-
zoites 24 h later. Thereafter, standard procedures were used
(Silvie et al., 2008b). Merosomes were harvested and
counted in a Neubauer chamber 72 h after infection. Infectiv-
ity of in vitro cultured ANKA-GFP and palm
- parasites was
tested by injection of the complete merosome containing
liver-stage culture supernatants in naïve NMRI mice. All
animals were monitored for parasitaemia by daily Giemsa-
stained thin blood smears.
Immunization and parasite challenge experiments
Age-matched female C57BL/6 mice were immunized with
two doses of 1000 or 10 000 palm
- sporozoites extracted
from salivary glands of infected mosquitoes. Sporozoites
were injected intravenously in a volume of 100 ml. For the
prime/boost protocol, animals that remained malaria-free
after the ﬁrst immunization were given a second dose 5–7
weeks after the ﬁrst immunization. Only animals that
remained blood-stage parasite-negative after the ﬁrst immu-
nization and subsequent boost were used for the challenge
experiments at 4–6 weeks after the last immunization. Mice
were challenged with ﬁve ANKA-GFP-infected mosquitoes,
10 000 intravenously injected ANKA-GFP sporozoites, or 10
intravenously injectedANKA-GFP blood-stage parasites. The
number of ANKA-GFP salivary gland sporozoites per mos-
quito used for the challenge by bite ranged from 20 000 to
70 000. At least three age-matched naïve animals were
included to verify infectivity of sporozoites during all chal-
lenge experiments. Parasitaemia was monitored by daily
Giemsa-stained thin blood smears, starting from day 3 after
immunization or ANKA-GFP challenge until at least day 17.
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